Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Rofecoxib and Bupivacaine to Prevent Pain After Third Molar (Wisdom Tooth) Extraction
This study has been completed.
Study NCT00050362 Information provided by National Institutes of Health Clinical Center (CC)
First Received: December 4, 2002 Last Updated: March 3, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Pain
Tooth Extraction
Interventions listed in this trial
Rofecoxib and Bupivacaine
Additional drug interventions recognized in this trial
Bupivacaine
Rofecoxib
More general drug interventions related to this trial
Analgesics
Analgesics, Non-Narcotic
Anesthetics
Anesthetics, Local
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Antirheumatic Agents
Central Nervous System Agents
Central Nervous System Depressants
Cyclooxygenase 2 Inhibitors
Cyclooxygenase Inhibitors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
National Institute of Dental and Craniofacial Research (NIDCR)
Back to top of Main Content
